Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 | AAPG Stock NewsStockTitan·Feb 5 at 09:30 AMAAPG-0.68%
SOPHARMA AD - Notification from Ivan Badinski under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000002262Polish Emitent·Jan 26 at 07:20 AMAAPGV0.00%
Ascentage Pharma presents four-year follow-up data on Olverembatinib for TKI-resistant/intolerant CML-CP at ASH 2025, reaffirming long-term efficacy and safety in a registrational Phase II study.Unusual Whales·Dec 8, 2025 at 06:47 PMAAPGV0.00%
Ascentage Pharma presents Phase II China study on Lisaftoclax at ASH Annual Meeting, supporting NDA approval by NMPA in July 2025.Unusual Whales·Dec 6, 2025 at 09:15 AMAAPG-0.68%AAPGV0.00%
Ascentage Pharma’s Olverembatinib Shows Promise in Rare GIST TreatmentTip Ranks·Nov 25, 2025 at 07:30 AMAAPGV0.00%AAPG-0.68%
Ascentage Pharma Reports Revenue Decline Amidst Strategic Drug ApprovalsTip Ranks·Aug 20, 2025 at 06:08 PMAAPG-0.68%AAPGV0.00%
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA | AAPG Stock NewsStockTitan·Aug 17, 2025 at 06:30 PM06855+2.96%AAPG-0.68%
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL | AAPG Stock NewsStockTitan·Jun 15, 2025 at 06:30 PMAAPG-0.68%AAPGV0.00%
Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress | AAPG Stock NewsStockTitan·Jun 9, 2025 at 06:30 PMAAPG-0.68%AAPGV0.00%
Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025 | AAPG Stock NewsStockTitan·May 22, 2025 at 07:15 PMAAPG-0.68%AAPGV0.00%
Top 18 mid-cap gainers last week include Ascentage Pharma (AAPG) up 38.35% and Ardagh Metal Packaging (AMBP) up 38.66%.Unusual Whales·May 7, 2025 at 09:42 PMAAPGV0.00%AAPG-0.68%
